fluenz
medimmune llc - reassortant influenza virus (live attenuated) of the following strains:a/california/7/2009 (h1n1)pdm09 like strain, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain - influenza, human; immunization - vaccines - prophylaxis of influenza in individuals 24 months to less than 18 years of age.the use of fluenz should be based on official recommendations.
fluenz tetra
astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influenza, human - influenza vaccines, influenza, live attenuated - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. the use of fluenz tetra should be based on official recommendations.
pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)
astrazeneca ab - reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.pandemic influenza vaccine h5n1 astrazeneca should be used in accordance with official guidance
flumist spray
astrazeneca canada inc - influenza virus type a (h1n1); influenza virus type a (h3n2); influenza virus type b - spray - 10000000ffu; 10000000ffu; 10000000ffu - influenza virus type a (h1n1) 10000000ffu; influenza virus type a (h3n2) 10000000ffu; influenza virus type b 10000000ffu - vaccines
flumist quadrivalent spray
astrazeneca canada inc - influenza virus type a (h1n1); influenza virus type a (h3n2); influenza virus type b (victoria); influenza virus type b (yamagata) - spray - 32000000ffu; 32000000ffu; 32000000ffu; 32000000ffu - influenza virus type a (h1n1) 32000000ffu; influenza virus type a (h3n2) 32000000ffu; influenza virus type b (victoria) 32000000ffu; influenza virus type b (yamagata) 32000000ffu - vaccines
fluenz tetra vaccine nasal suspension 0.2ml unit dose
astrazeneca uk ltd - influenza virus live attenuated - spray
fluarix
glaxo smith kline (israel) ltd - a/california/7/2009 (h1n1) 15 mcg / 0.5 ml; a/victoria/361/2011 (h3n2) 15 mcg / 0.5 ml - suspension for injection - influenza, live attenuated - prophylaxis of influenza, especially those who run an increased risk of associated complications. fluarix is indicated in adults and children from 6 months of age.
fluenz vaccine nasal suspension 0.2ml unit dose
astrazeneca uk ltd - influenza virus live attenuated - spray
flumist quadrivalent vaccine nasal suspension 0.2ml unit dose
astrazeneca uk ltd - influenza virus live attenuated - spray